PVB With vs. Without Clonidine for Ventral Hernia Repair
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02505204 |
Recruitment Status :
Suspended
First Posted : July 22, 2015
Last Update Posted : January 19, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Paravertebral block (PVB) combined with light intravenous sedation was associated with a short hospital stay, less post-operative nausea and vomiting and reduced analgesic consumption compared to general anesthesia for ventral hernia repair. Given the effectiveness of PVB in the ventral hernia repair, it would be beneficial to study the effect of PVB with versus without clonidine in elderly patients.
Patients will be randomly allocated to one of 2 groups with 30 patients in each, using the sealed envelope technique. Group one will receive PVB with clonidine while group 2 will receive PVB with placebo.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ventral Hernia Repair | Other: Clonidine Other: Placebo | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Other |
Official Title: | Paravertebral Block With Versus Without Clonidine for Patients Undergoing Ventral Hernia Repair: A Prospective Double-blinded Randomized Study |
Actual Study Start Date : | August 1, 2015 |
Estimated Primary Completion Date : | April 2021 |
Estimated Study Completion Date : | April 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Clonidine
Will receive bilateral PVB with clonidine.
|
Other: Clonidine
The anesthetic mixture will contain: lidocaine 2% 7 mL, lidocaine 2% 6 mL with epinephrine 5µg.mL-1, bupivacaine 0.5% 5 mL, and clonidine 2 mL. |
Placebo Comparator: Placebo
Will receive bilateral PVB with placebo.
|
Other: Placebo
the same anesthetic mixture will be administrated however the clonidine will be substituted with 2 mL saline. |
- Hemodynamic stability recorded from electrocardiogram and pulse oximeter [ Time Frame: within the first 48 hours after surgery ]Compare the hemodynamic stability between the two groups
- Postoperative nausea and vomiting recorded via questionnaire [ Time Frame: within the first 48 hours after surgery ]Comparison of postoperative nausea and vomiting between the two groups
- Postoperative analgesic consumption recorded via questionnaire [ Time Frame: within the first 48 hours after surgery ]Comparison of analgesic consumption between the two groups

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients scheduled for ventral hernia repair whose age is 65 years and older
- and with ASA greater or equal to 2
Exclusion Criteria:
- History of allergic reactions to local anesthetics
- Bleeding diatheses
- Spinal abnormality

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02505204
Lebanon | |
Makassed General Hospital | |
Beirut, Lebanon |
Principal Investigator: | Zoher Naja, MD | Chairperson of Anesthesia department |
Responsible Party: | Zoher Naja, Chairperson of Anesthesia and Pain Management Department, Makassed General Hospital |
ClinicalTrials.gov Identifier: | NCT02505204 |
Other Study ID Numbers: |
07/09/2015 |
First Posted: | July 22, 2015 Key Record Dates |
Last Update Posted: | January 19, 2021 |
Last Verified: | January 2021 |
clonidine paravertebral block hemodynamic stability |
Hernia Hernia, Ventral Pathological Conditions, Anatomical Hernia, Abdominal Clonidine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Antihypertensive Agents Sympatholytics Autonomic Agents Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |